Jing Song Wang
Amministratore Delegato presso HBM HOLDINGS LIMITED
Profilo
Dr. Jing Song Wang is an Independent Non-Executive Director at InSilico Medicine Cayman TopCo, an Independent Director at Xinjiang Baihuacun Pharam Tech Co., Ltd., a Chairman & Chief Executive Officer at Harbour BioMed (Shanghai) Co., Ltd., an Independent Non-Executive Director at Silicon INSITE, Inc., a Chairman & Chief Executive Officer at HBM Holdings Ltd., a Chief Executive Officer at Hbm Guangzhou, a Chief Executive Officer at Hbm Suzhou Co. Ltd.
and an Independent Non-Executive Director at Frontage Holdings Corp.
He is on the Board of Directors at InSilico Medicine Cayman TopCo, Xinjiang Baihuacun Pharam Tech Co., Ltd., Silicon INSITE, Inc. and Frontage Holdings Corp.
Dr. Wang was previously employed as a Head-Research & Development by Sanofi (China) Investment Co. Ltd.
He received his graduate degree from Jilin University, a graduate degree from Xuzhou Medical University and a doctorate degree from China Pharmaceutical University.
Posizioni attive di Jing Song Wang
| Società | Posizione | Inizio |
|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Direttore/Membro del Consiglio | - |
| HBM HOLDINGS LIMITED | Amministratore Delegato | 20/07/2016 |
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Direttore/Membro del Consiglio | 17/09/2021 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Amministratore Delegato | 01/12/2016 |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 01/08/2016 |
| Hbm Suzhou Co. Ltd. | Amministratore Delegato | - |
| Hbm Guangzhou | Amministratore Delegato | - |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Direttore/Membro del Consiglio | 01/06/2023 |
Precedenti posizioni note di Jing Song Wang
| Società | Posizione | Fine |
|---|---|---|
| Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | 01/12/2015 |
Formazione di Jing Song Wang
| China Pharmaceutical University | Doctorate Degree |
| Jilin University | Graduate Degree |
| Xuzhou Medical University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| FRONTAGE HOLDINGS CORPORATION | Health Technology |
| HBM HOLDINGS LIMITED | Health Technology |
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Commercial Services |
| Aziende private | 6 |
|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
| Hbm Suzhou Co. Ltd. | |
| Hbm Guangzhou | |
| Sanofi (China) Investment Co. Ltd. | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
- Borsa valori
- Insiders
- Jing Song Wang
